RxDoctor Payments Data

Mona Attalla

Physician Assistant · Porterville, CANPI 1073633301

Payments from drug & device makers

$4,527in general payments, 2019–2025

Across 195 payments — averaging $23.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$531
  • AbbVie$531
  • Lilly USA, LLC$464
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$299
  • Boehringer Ingelheim$272
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$4,527100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,527 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide44$40,345
JanuviaSitagliptin Phosphate15$17,664
FarxigaDapagliflozin Propanediol13$11,957
JardianceEmpagliflozin12$6,223
LinzessLinaclotide11$6,168
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$2,787
Albuterol Sulfate HfaAlbuterol Sulfate33$1,196
Aripiprazole20$1,101
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen55$920
Omeprazole91$791
Phenobarbital11$592
Atorvastatin Calcium106$591
Metformin Hcl119$584
Lisinopril135$462
Levothyroxine Sodium50$380

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,316$40,34544 claims
AstraZenecaFarxiga$531$11,95713 claims
Boehringer IngelheimJardiance$272$6,22312 claims
AbbVieLinzess$531$6,16811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Porterville

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →